Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vitanova Biomedical, Inc. (VNB) is a San Antonio, TX-based early stage biotechnology company developing patented (pending) technology licensed from the University of Texas at San Antonio. The company’s cancer treatment, Light-Activated Intracellular Acidosis (LAIA), is based upon three accepted principles of cancer therapy: 1) Intracellular acidosis causes rapid pH-induced cancer cell death; 2) Compounds can be activated by ...
Vitanova Biomedical, Inc. (VNB) is a San Antonio, TX-based early stage biotechnology company developing patented (pending) technology licensed from the University of Texas at San Antonio. The company’s cancer treatment, Light-Activated Intracellular Acidosis (LAIA), is based upon three accepted principles of cancer therapy: 1) Intracellular acidosis causes rapid pH-induced cancer cell death; 2) Compounds can be activated by specific wavelengths of light; and 3) Nanoparticles can be selectively targeted to specific cancer types using antibody-antigen conjugates.

List your booth number for exhibitions, ask us